Griffith University and Thermo Fisher Scientific have signed a five-year Memorandum of Understanding (MoU) to establish a strategic partnership focused on advancing innovation across health, biotechnology and translational research, anchored within the Gold Coast Health & Knowledge Precinct (GCHKP).
The partnership brings together Griffith’s strengths in biomanufacturing, glycoproteomics and next-generation therapeutics with Thermo Fisher’s global capability in analytical instruments, diagnostics, laboratory technologies and biotechnology services. Together, the organisations will explore opportunities to accelerate research translation, strengthen commercialisation pathways and build capability across the Precinct’s innovation ecosystem.
The GCHKP will provide a strategic environment for this collaboration, supporting closer connection between research, industry, infrastructure and clinical capability. Through the MoU, Griffith and Thermo Fisher will explore a shared innovation and co-lab space within the Precinct to support co-location, access to specialist laboratories and equipment, and future Thermo Fisher presence within the ecosystem.
The organisations will also collaborate on research in glycoproteomics, spatial-omics, mass spectrometry, robotic sample processing and other enabling technologies, while pursuing joint grants and exploring the potential for a future Centre of Excellence. The MoU also creates opportunities to support a deep technology incubator, expand workforce capability, and develop student placements, internships and broader training initiatives.
